@thepinkribbondoctor: 🎀 Let’s talk about Verzenio and Kisqali, breast besties! Both are CDK4/6 inhibitors used in certain patients with hormone receptor-positive, HER2-negative breast cancer. When added to appropriate hormone therapy, these medications can help reduce the risk of recurrence in certain patients with early-stage disease and slow cancer growth in advanced disease. But they can come with side effects! 💗 Verzenio (abemaciclib): Diarrhea is especially common. Hydration, prompt use of prescribed antidiarrheal medication, and dietary adjustments may help. 💗 Kisqali (ribociclib): Low white blood cell counts are common. It can also affect liver function and heart rhythm, so regular blood work and ECG monitoring are important. Both medications can cause fatigue, nausea, and other side effects. Here’s what I want you to remember: These medications can offer meaningful benefits, but they aren’t recommended for everyone. Your cancer stage, recurrence risk, overall health, and treatment goals matter. Don’t stop or adjust your medication without talking to your medical oncologist. Did you take Verzenio or Kisqali? What was your hardest side effect, and what helped you manage it? Your experience may help another breast bestie! 🎀 Follow The Pink Ribbon Doctor for honest, evidence-based breast cancer education. Are you Newly diagnosed with breast cancer and facing breast cancer surgery? I offer virtual second opinion consultations to help you better understand your diagnosis and surgical options. Book through the link in my bio! #breastcancer #BreastCancerAwareness #verzenio #cdkinhibitor #kisqali

thepinkribbondoctor

Open In TikTok:

Region: US

Monday 09 November 2026 15:10:38 GMT